# DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval

Study · id `cardio:ct-nct03494920` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03494920](<https://clinicaltrials.gov/study/NCT03494920>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03494920

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 295 participants.

## Technical summary

Registry record NCT03494920. Randomized; single masking; primary purpose treatment. Start 2018-04-27 (actual); primary completion 2021-09-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 295 participants (enrolled count; ClinicalTrials.gov record NCT03494920, source copy `cardio:ctgov-nct03494920-2022-06-16`, retrieved 2026-10-26)
- Started: 2018-04-27 (actual) (ClinicalTrials.gov record NCT03494920, source copy `cardio:ctgov-nct03494920-2022-06-16`, retrieved 2026-10-26)
- Primary completion: 2021-09-08 (actual) (ClinicalTrials.gov record NCT03494920, source copy `cardio:ctgov-nct03494920-2022-06-16`, retrieved 2026-10-26)
- Completion: 2021-09-08 (actual) (ClinicalTrials.gov record NCT03494920, source copy `cardio:ctgov-nct03494920-2022-06-16`, retrieved 2026-10-26)
- Countries: Australia; China; Singapore; Vietnam (ClinicalTrials.gov record NCT03494920, source copy `cardio:ctgov-nct03494920-2022-06-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03494920-2022-06-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval Versus Standard Bridging Thrombolysis With Endovascular Clot Retrieval
- Condition: Ischemic Stroke
- Intervention (Other): Direct endovascular clot retrieval
- Intervention (Other): Bridging thrombolysis followed by ECR
- Lead sponsor: Neuroscience Trials Australia
- Lead sponsor class: OTHER
- Collaborator: The Florey Institute of Neuroscience and Mental Health
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Neuroscience Trials Australia (`cardio:org-neuroscience-trials-australia`)
- Registry lists this organization as a collaborator: The Florey Institute of Neuroscience and Mental Health (`cardio:org-the-florey-institute-of-neuroscience-and-mental-health`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial (`cardio:pubmed-35810757`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7afbd12f10574b625d36303328af23b28158eb5af211e22cba675b8d974f402f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
